tovorafenib,vorasidenib
servier,spdr s&p biotech,day one biopharmaceutical
['tovorafenib', 'vorasidenib', 'dayone', '$xbi', 'servier', '$dawn']
new era in glioma: two standout #asco23 data presentations from for #vorasidenib and for #tovorafenib should bring new therapies to glioma patients $dawn $xbi 
The leading voice for decision-makers throughout the global biopharma ecosystem. 
Free weekly podcast "BioCentury This Week": https://t.co/6CfHh0mIT6